Zoetis Inc. (ZTS) earnings on August 6, 2026

Before the market opens Q2 2026

More Zoetis Inc. earnings

Prior outlook: Pessimistic Outcome: Partial

The stock rose 3.8% despite weak pet health demand and a downgrade, showing resilience after a volatile session.

ZTS price around the earnings

77.27

Change: +3.9%

2026-08-06, 20:00 UTC

Start of the measured window End of the measured window
71.40 73.93 76.45 78.98 74.40
Price series around the eventClosing price per minute from before the event to the end of the measured window.
August 6, 2026
  • Price: green if it ends above the starting price; red if it ends below
  • Start of the measured window
  • End of the measured window
  • Market open
  • Starting price
Price series around the event

Prior thesis

Prior outlook: Pessimistic Outcome: Partial

Thesis published
Results released

Analysts maintain high upside targets despite recent price target cuts; Q1 was a miss. Trajectory collapsed into event.

Context analyzed before publication

Trend
Price trajectory collapsed significantly into the event, indicating an extreme selloff from prior positive trend strength.

Analysts

Evidence

Analyst consensus
Buy
Consensus average (1-5)
2
Analysts covering the stock
16
Average price target
110.81
Lowest price target
80
Highest price target
160
Upside to price target
49%
Quarterly earnings growth
-0.2%
Revenue growth
2.9%
Forward EPS
7.39
Trailing EPS
5.97
Analyst moves in the last 60 days
6
  • Strong buy: 3
  • Buy: 8
  • Hold: 8
  • Sell: 0
  • Strong sell: 0
Strong buy
3
Buy
8
Hold
8
Sell
0
Strong sell
0
  • July 27, 2026 · UBS: Maintains rating (Neutral → Neutral)
  • July 22, 2026 · Morgan Stanley: Maintains rating (Overweight → Overweight)
  • July 6, 2026 · HSBC: Maintains rating (Buy → Buy)
  • July 1, 2026 · Barclays: Maintains rating (Equal-Weight → Equal-Weight)
  • June 30, 2026 · TD Cowen: Maintains rating (Buy → Buy)
  • June 26, 2026 · Stifel: Maintains rating (Hold → Hold)

Technicals

Evidence

Price when the context was analyzed
74.4
Average true range (ATR)
3.2%
Distance to 52-week high
-51.6%
14-day change (14d)
+0.3%
30-day change (30d)
-1.3%
30-day relative strength
-3.8%
SPY change (30d)
+2.5%
Nearest support
74.22
Distance to nearest support
0.2%
Nearest resistance
74.64
Distance to nearest resistance
0.3%
Volume accumulation ratio (14d / 46d)
0.79
  • Mid: 74.22 (0.2% away, 0.07 ATR, 12 touches)
  • Mid: 73.63 (1% away, 0.32 ATR, 18 touches)
  • Mid: 73.02 (1.9% away, 0.58 ATR, 13 touches)
  • Mid: 74.64 (0.3% away, 0.1 ATR, 13 touches)
  • Mid: 75.61 (1.6% away, 0.5 ATR, 25 touches)
  • Mid: 76.01 (2.2% away, 0.67 ATR, 13 touches)

Trends

Evidence

Average earnings surprise
+3.5%
  • May 7, 2026: actual EPS 1.53 vs estimate 1.62 (surprise -5.3%)
  • February 12, 2026: actual EPS 1.48 vs estimate 1.4 (surprise +5.5%)
  • November 4, 2025: actual EPS 1.7 vs estimate 1.62 (surprise +4.8%)
  • August 5, 2025: actual EPS 1.76 vs estimate 1.61 (surprise +9.2%)

Expected move

Implied move
+3.9%
Source
Options chain

Reactions over its last 20 earnings

Median move
5%
75th percentile move
6.1%
90th percentile move
11.2%
Up / down moves
8 / 12
Average up move
+4.0%
Average down move
-6.7%

Monitoring and close

What Zoetis Inc. reported

Status
Finished
Actual EPS1.87
EPS estimate1.86
EPS surprise+0.5%
Revenue$2,468 million
Revenue estimate$2,502 million
Revenue surprise-1.4%

Zoetis beat Q2 earnings estimates but missed revenue and cut its 2026 outlook. The outlook remains pessimistic after the guidance reduction.

Sources (16)

Pre-market second reading after the results

Verdict
Beat expectations

Heading into the open, results beat expectations on earnings but not on revenue, and the price is indicating +0.8% pre-market, a move below the stock's usual reaction (about 5%). The figures don't confirm the prior scenario: that move is too small to draw conclusions from.

How the stock reacted

Outcome
Partial
Consolidated
+3.8%
Max favorable move (MFE)
5.9%
Max adverse move (MAE)
7.2%